The Study Of Export Competitiveness In ZW Ltd Company

Along with the accelerating pace of life and the worsening Earth’s pollution in the21st century, significant changes have occurred in the spectrum of human disease resulting in the treatment of non-communicable diseases, health products, future demand the use of generic drugs in Medicare,which are pulling the excipient market development. Although major international economies have been affected by the economic crisis hit, the particularity of pharmaceuticals limited the negative impact on pharmaceutical excipients. But at the same time, the law in the main sales market for pharmaceutical excipients and import management is still a major bottleneck of pharmaceutical excipients export in ChinaAs far as the domestic environment, despite lower prices of raw materials, labor and national support opportunities for the development of pharmaceutical excipients, Chinese pharmaceutical enterprises are faced with inconsistent quality of raw materials, insufficient research and development capabilities, the plight of low-level competition in the industry, TNCs’ direct landing excipient market with a view to compensating market loss due to falling sales in Europe and America.Aims to the export competitiveness for pharmaceutical excipients, This paper explore PEST Analytical Methods to analyze the company’s macro-environment and explore SWOT Analytical Methods to examine the company’s competitive to sharp advantages and disadvantages and conclude company’s core competitiveness. On this basis, build companies alternative strategies, and analyze the feasibility of an alternative strategy, and create a clear development strategy for differentiation strategy, present the implementation and suggestions, includes Increasing technological innovation, operating international marketing, strengthen financial capacity, developing human resources, quality controlling, creating information systems, improving the export competitiveness.